A Study of Elpipodect (MK-8189) Human Absorption, Metabolism, and Excretion in Healthy Male Participants (MK-8189-010)

A Phase 1 Clinical Study to Evaluate the Absorption, Metabolism and Excretion of [14C]MK-8189 in Healthy Adults

The purpose of this study is to learn what happens to elpipodect in a healthy person's body over time.

Inclusion Criteria:

Key inclusion criteria include but are not limited to the following:

• Is in good health based on medical history, physical examination, VS measurements, and ECGs performed before randomization.
• Has a BMI ≥19 and ≤32 kg/m2, inclusive, at screening

Exclusion Criteria:

The key exclusion criteria include but are not limited to the following:

• Has a history of clinically significant endocrine, gastrointestinal (GI), cardiovascular, hematological, hepatic, immunological, renal, respiratory, genitourinary, or major neurological (including stroke and chronic seizures) abnormalities or diseases.
• Has a history of cancer.